HealthLeaders Media February 16, 2024
KFF Health News

The law represents the most significant overhaul for the U.S. drug marketplace in decades.

KEY TAKEAWAYS

– With Election Day on the horizon, the president is trying to make sure voters know who is responsible for the lower prices. This month, the White House began a campaign to get the word out to seniors.

– The restructuring of Medicare Part D is already lowering costs for many Medicare patients who spent more than $3,500 a year on their Part D drugs. In 2020 that was about 1.3 million patients, 200,000 of whom spent $5,000 or more out-of-pocket.

This article was published on Friday, February 16, 2024 in KFF Health News.

By Arthur Allen

Last year alone, David Mitchell paid $16,525...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech
Shifting Our Healthcare Delivery Model from Reactive to Proactive
Medtronic, Tempus testing AI to find potential TAVR patients
Why Tufts Medicine ended its hospital-at-home program
How the Triadic Model of Interpreter, Patient and Provider has Elevated Healthcare Communications
Is a lack of understanding driving alcohol-related deaths in the U.S.?

Share This Article